清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

An insight of microRNAs performance in carcinogenesis and tumorigenesis; an overview of cancer therapy

重编程 小RNA 癌变 生物 转移 癌症 癌症研究 生物信息学 靶向治疗 计算生物学 细胞 遗传学 基因
作者
Kosar Babaei,Shima Shams,Arman Keymoradzadeh,Sogand Vahidi,Parisa Hamami,Roya Khaksar,Seyedeh Elham Norollahi,Ali Akbar Samadani
出处
期刊:Life Sciences [Elsevier BV]
卷期号:240: 117077-117077 被引量:54
标识
DOI:10.1016/j.lfs.2019.117077
摘要

Importance of dysregulation and expression of microRNAs (miRNAs) has been confiemed in many disorders comprising cancer. In this way, different approaches to induce reprogramming from one cell type to another in oerder to control the cell normal mechanisem, comprising microRNAs, combinatorial small molecules, exosome-mediated reprogramming, embryonic microenvironment and also lineage-specific transcription agents, are involved in cell situation. Meaningly, besides the above factors, microRNAs are so special and have an impressive role in cell reprogramming. One of the main applications of cancer cell reprogramming is it's ability in therapeutic approach. Many insights in reprogramming mechanism have been recommended, and determining improvment has been aknolwged to develop reprogramming efficiency and possibility, permiting it to appear as practical therapy against all cancers. Conspiciously, the recent studies on the fluctuations and performance of microRNAs,small endogenous non-coding RNAs, as notable factors in carcinogenesis and tumorigenesis, therapy resistance and metastasis and as new non-invasive cancer biomarkers has a remarkable attention. This is due to their unique dysregulated signatures throughout tumor progression. Recognising miRNAs signatures capable of anticipating therapy response and metastatic onset in cancers might enhance diagnosis and therapy. According to the growing reports on miRNAs as novel non-invasive biomarkers in various cancers as a main regulators of cancers drug resistance or metastasis, the quest on whether some miRNAs have the ability to regulate both simultaneously is inevitable, yet understudied. The combination of genetic diagnosis using next generation sequencing and targeted therapy may contribute to the effective precision medicine for cancer therapy. Here, we want to review the practical application of microRNAs performance in carcinogenesis and tumorigenesis in cancer therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
怡然白竹完成签到 ,获得积分10
4秒前
居里姐姐完成签到 ,获得积分10
5秒前
14秒前
研友_VZG7GZ应助科研通管家采纳,获得10
15秒前
hjyylab应助科研通管家采纳,获得10
15秒前
15秒前
23秒前
迈克老狼完成签到 ,获得积分10
23秒前
chenjun7080完成签到,获得积分10
24秒前
26秒前
喜悦的香之完成签到 ,获得积分10
26秒前
小杨完成签到 ,获得积分10
26秒前
monk完成签到 ,获得积分10
27秒前
liuliu完成签到 ,获得积分10
28秒前
默默完成签到 ,获得积分10
28秒前
术士1000发布了新的文献求助30
29秒前
积极鸵鸟完成签到 ,获得积分10
36秒前
醉熏的千柳完成签到 ,获得积分10
48秒前
心想事成完成签到 ,获得积分10
49秒前
宅心仁厚完成签到 ,获得积分10
53秒前
斯文的芹菜完成签到 ,获得积分10
56秒前
任伟超完成签到,获得积分10
1分钟前
1分钟前
1分钟前
Yini发布了新的文献求助10
1分钟前
hao给hao的求助进行了留言
1分钟前
xu完成签到,获得积分10
1分钟前
陈JY完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
yuhang发布了新的文献求助30
1分钟前
段誉完成签到 ,获得积分10
1分钟前
神勇的罡发布了新的文献求助10
1分钟前
应樱完成签到 ,获得积分10
2分钟前
斯文败类应助科研通管家采纳,获得10
2分钟前
cdercder应助科研通管家采纳,获得10
2分钟前
cdercder应助科研通管家采纳,获得10
2分钟前
cdercder应助科研通管家采纳,获得10
2分钟前
牛奶拌可乐完成签到 ,获得积分10
2分钟前
firesquall完成签到,获得积分10
2分钟前
高分求助中
Thinking Small and Large 500
Algorithmic Mathematics in Machine Learning 500
Mapping the Stars: Celebrity, Metonymy, and the Networked Politics of Identity 400
Getting Published in SSCI Journals: 200+ Questions and Answers for Absolute Beginners 300
Engineering the boosting of the magnetic Purcell factor with a composite structure based on nanodisk and ring resonators 240
Study of enhancing employee engagement at workplace by adopting internet of things 200
Minimum Bar Spacing as a Function of Bond and Shear Strength 200
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3837565
求助须知:如何正确求助?哪些是违规求助? 3379667
关于积分的说明 10510106
捐赠科研通 3099269
什么是DOI,文献DOI怎么找? 1707029
邀请新用户注册赠送积分活动 821402
科研通“疑难数据库(出版商)”最低求助积分说明 772615